Selective blockade of central m1 muscarinic cholinergic receptors with pirenzepine impairs cardiovascular and respiratory function in rats with acute hemorrhage.
Ultrasound studies showed that selective antagonist of central M1 muscarinic cholinergic receptors pirenzepine (50 mg/kg intravenously) causes transitory hypotension and respiratory depression in anesthetized intact rats. The M1 receptor antagonist had no effect on cardiac output and portal blood flow. Pretreatment with pirenzepine increased the sensitivity of rats with acute massive hemorrhage to circulatory hypoxia. After blockade of central M1 muscarinic cholinergic receptors, the posthemorrhagic period was characterized by primary decompensation of blood pressure, portal blood flow, and respiration and development of low cardiac output syndrome. The animals died over the first minutes after bleeding arrest. Our results indicate that central M1 muscarinic cholinergic receptors act as shock-limiting cholinergic structures under conditions of posthemorrhagic changes in systemic and portal blood flow, as well as during respiratory dysfunction.
Kovalenko
N Ya
NY
Institute of General Pathology and Pathophysiology, Russian Academy of Medical Sciences, Moscow.
Matsievskii
D D
DD
D000818:Animals; D002319:Cardiovascular System / Q000187:drug effects*; D006470:Hemorrhage / Q000150:complications*; D008297:Male; D018727:Muscarinic Antagonists / Q000494:pharmacology*; D010890:Pirenzepine / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D011976:Receptors, Muscarinic / Q000378:metabolism*; D012143:Respiratory Physiological Phenomena / Q000187:drug effects*; D013997:Time Factors
D018727:Muscarinic Antagonists; D011976:Receptors, Muscarinic; D010890:Pirenzepine